Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer
- PMID: 17923866
- PMCID: PMC2360467
- DOI: 10.1038/sj.bjc.6604027
Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer
Abstract
There is increasing evidence that the presence of a systemic inflammatory response plays an important role in predicting survival in patients with colorectal cancer. However, it is not clear what components of the systemic inflammatory response best predict survival. The aim of the present study was to compare the prognostic value of an inflammation-based prognostic score (modified Glasgow Prognostic Score (Mgps) 0=C-reactive protein <10 mg l(-1), 1=C-reactive protein >10 mg l(-1), and 2=C-reactive protein >10 mg l(-1) and albumin<35 g l(-1)) with that of components of the white cell count (neutrophils, lymphocytes, monocytes and platelets using standard thresholds) in patients with colorectal cancer. Two patient groups were studied: 149 patients who underwent potentially curative resection for colorectal cancer and 84 patients who had synchronous unresectable liver metastases. In those patients who underwent potentially curative resection the minimum follow-up was 36 months and 20 patients died of their cancer. On multivariate survival analysis only TNM stage (HR 3.75, 95% CI 1.54-9.17, P=0.004), monocyte count (HR 3.79, 95% CI 1.29-11.12, P=0.015) and mGPS (HR 2.21, 95% CI 1.11-4.41, P=0.024) were independently associated with cancer-specific survival. In patients with synchronous unresectable liver metastases the minimum follow-up was 6 months and 71 patients died of their cancer. On multivariate survival analysis only single liver metastasis >5 cm (HR 1.78, 95% CI 0.99-3.21, P=0.054), extra-hepatic disease (HR 2.09, 95% CI 1.05-4.17, P=0.036), chemotherapy treatment (HR 2.40, 95% CI 1.82-3.17, P<0.001) and mGPS (HR 1.44, 95% CI 1.01-2.04, P=0.043) were independently associated with cancer-specific survival. In summary, markers of the systemic inflammatory response are associated with poor outcome in patients with either primary operable or synchronous unresectable colorectal cancer. An acute-phase protein-based prognostic score, the mGPS, appears to be a superior predictor of survival compared with the cellular components of the systemic inflammatory response.
Figures
Similar articles
-
Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.World J Gastroenterol. 2015 Nov 21;21(43):12410-20. doi: 10.3748/wjg.v21.i43.12410. World J Gastroenterol. 2015. PMID: 26604648 Free PMC article.
-
Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer.World J Surg. 2011 Aug;35(8):1861-6. doi: 10.1007/s00268-011-1130-7. World J Surg. 2011. PMID: 21538187
-
Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer.Br J Cancer. 2013 Jul 9;109(1):24-8. doi: 10.1038/bjc.2013.330. Epub 2013 Jun 25. Br J Cancer. 2013. PMID: 23799846 Free PMC article.
-
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?Clin Colorectal Cancer. 2017 Dec;16(4):264-274. doi: 10.1016/j.clcc.2017.03.015. Epub 2017 Mar 24. Clin Colorectal Cancer. 2017. PMID: 28412137 Review.
-
Prognostic Value of the Glasgow Prognostic Score or Modified Glasgow Prognostic Score for Patients with Colorectal Cancer Receiving Various Treatments: a Systematic Review and Meta-Analysis.Cell Physiol Biochem. 2018;51(3):1237-1249. doi: 10.1159/000495500. Epub 2018 Nov 27. Cell Physiol Biochem. 2018. PMID: 30481755
Cited by
-
A predictive model for colorectal cancer complicated with intestinal obstruction based on specific inflammation score.BMC Cancer. 2024 Aug 22;24(1):1035. doi: 10.1186/s12885-024-12806-5. BMC Cancer. 2024. PMID: 39169325 Free PMC article.
-
Neutrophil and lymphocyte counts at diagnosis are associated with overall survival of pancreatic cancer: A retrospective cohort study.Medicine (Baltimore). 2016 Oct;95(40):e5024. doi: 10.1097/MD.0000000000005024. Medicine (Baltimore). 2016. PMID: 27749562 Free PMC article.
-
Pre-treatment psoas major volume is a predictor of poor prognosis for patients with epithelial ovarian cancer.Mol Clin Oncol. 2019 Oct;11(4):376-382. doi: 10.3892/mco.2019.1912. Epub 2019 Aug 19. Mol Clin Oncol. 2019. PMID: 31497297 Free PMC article.
-
Association between inflammation-based prognostic markers and mortality of non-cardiac surgery.Korean J Anesthesiol. 2023 Dec;76(6):550-558. doi: 10.4097/kja.23068. Epub 2023 Feb 24. Korean J Anesthesiol. 2023. PMID: 36824044 Free PMC article.
-
Prognostic Value of Post-Operative C-Reactive Protein-Based Inflammatory Biomarkers in Colorectal Cancer Patients: Systematic Review and Meta-Analysis.Clin Epidemiol. 2023 Jun 27;15:795-809. doi: 10.2147/CLEP.S415171. eCollection 2023. Clin Epidemiol. 2023. PMID: 37396024 Free PMC article. Review.
References
-
- American Joint Committee on Cancer (2002) Colon and rectum. In Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M (eds) AJCC Cancer Staging Manual, 6th edn, pp 113–124. New York, NY: Springer
-
- Bruckner HW, Lavin PT, Plaxe SC, Storch JA, Livstone EM (1982) Absolute granulocyte, lymphocyte, and monocyte counts. Useful determinants of prognosis for patients with metastatic cancer of the stomach. JAMA 247: 1004–1006 - PubMed
-
- Carstairs V, Morris R (1991) Deprivation and Health in Scotland. Aberdeen: University Press
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials